News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

What Price Innovation? Understanding The Sovaldi Saga


5/30/2014 7:40:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The biopharmaceutical industry has been highly criticized for a number of years with respect to the high costs of medicines, particularly for drugs to treat cancer and rare diseases. Physicians and insurers have challenged the benefit of a new drug that might cost tens of thousands of dollars yet only extends life for a few months. This has led to various ethical debates about the value of life vs. the cost to society as a whole.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Forbes

comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES